rss
twitter
    Find out what I'm doing, Follow Me :)

Saturday 27 February 2016

Effect of Tuberculosis in pregnancy

 Pregnant woman infected with Tuberculosis

In 2005.WHO was declared a public health emergency for Tuberculosis. TB become more complicated in case of maternal mortality & is among the three leading causes of death among  of women aged 13-45 years.

If you infected by TB during pregnancy & you don’s treated it early, there is an increased risk of:

·        A chance of Miscarriage.

·        Premature Baby.

·        Baby burn with low birth weight.

·        Baby born with TB.
So proper treatment is vary necessary for TB infected pregnant woman.

Diagnosis:

If pregnant women are coughing up sputum( Phlegm) for more than three weeks, it must be go for sputum test which pick up most form of TB. This may be followed by a chest X-ray. Skin test or a blood test.If you have no specific symptom of TB,you will be given the tuberculosis test, also called Mantoux Test.

Treatment for TB during pregnancy

TB can  be fully cured  by using full  course of medication  (antibiotics) without interruption of medication. The course can go for between six and  nine months. Occasionally  the treatment  might go on for longer, depending on the severity of the case. Your doctor will tell you when it is safe to stop your medication.

You may feel better within a few weeks of treatment, but the bacteria will still be alive. So it is very important to complete the full course of medication. If you don't take the drugs as exactly prescribed, there is a very strong chance of a relapse. And you could pass the infection on to your family members. You may also end up with drug-resistant forms of the disease which are more difficult to treat.


Using of Directly Observed Therapy, Short Course (DOTS) is better option for treatment of TB with Pregnancy. This therapy entails the use of combination therapy for at least 6 months, depending on the combination of antituberculous agents that are available. This combination includes isoniazide and rifampicin compulsorily, supported by ethambutol and pyrazinamide .For patients with drug-susceptible TB and, these regimens will cure around 90% of TB cases. The use of these first-line antituberculosis drugs in pregnancy is considered safe for the mother and the baby by The British Thoracic Society, International Union against Tuberculosis and Lung Disease, and the World Health Organization.
 
Isoniazide
INH is safe during pregnancy even in the first trimester, though it can cross the placenta and may be cause of INH-induced hepatotoxicity. Pyridoxine supplementation is recommended for all pregnant women taking INH at a dose of 50mg daily.

Rifampicin
This is also believed to be safe in pregnancy, though there may be an increased risk of haemorrhagic disorders in the newborn (some authorities prescribe supplemental vitamin K (10mg/day) for the last four to eight weeks of pregnancy.)
Ethambutol
It may cause retro bulbar neuritis (optic neuritis) in adults because it may interfere with ophthalmological development when used in pregnancy but this has not been demonstrated when the standard dose is used. This was also confirmed in experimental studies on some abort uses.

 Pyrazinamide
The use of pyrazinamide in pregnancy was avoided by many physicians for a long time due to unavailability of adequate data on its teratogenicity. Presently, many international organizations now recommend its use. There are no reports of significant adverse events from the use of this drug in the treatment of TB in pregnant women despite its use as part of the standard regimen in many countries.
Its use is particularly indicated in women with tuberculosis meningitis in pregnancy, HIV infection, and suspected INH resistance.

Streptomycin
The drug has been proven to be potentially teratogenic throughout pregnancy. It causes fetal malformations and eighth-nerve paralysis, with deficits ranging from mild hearing loss to bilateral deafness. Many centres are against the use of this drug in pregnancy.

Multidrug-Resistant Tuberculosis  in Pregnancy

Pregnant women with MDR-TB have much difficult to treatment. They may sometimes require treatment with second-line drugs, including cycloserine, ofloxacin, amikacin, kanamycin, capreomycin, and ethionamide. The safety of these drugs is unfortunately not well-established in pregnancy.

Ethionamide is associated with growth retardation, central nervous system and skeletal abnormalities in early pregnancy. Its use is, therefore, not recommended in pregnancy.

Therapeutic abortion has been proposed as an option of management for these women, as MDR-TB poses more risk to the woman and the society at large. Another option is to delay initiating treatment to the second trimester where possible. Individualized Treatment Regimen (ITR) using various combinations of the 2nd line antituberculosis  agents based on their susceptibility profile had, however, been tried in some pregnant women with no adverse obstetric outcome
The outlook for those patients is expected to improve as experience and knowledge in the management of the condition increases.
In addition to your antibiotics, it is important to take good care of yourself so that you strengthen your immune system:
  • Eat a well balanced diet.
  • Get plenty of fresh air.
  • Don't miss antenatal visits of doctor.
  • Report any side effects, such as vision changes, headaches or increased nausea to your doctor immediately.

As long as you are infectious, maintain good  personal hygiene. Ensure that you wash your hands regularly and cover your mouth and nose with a tissue when you cough or sneeze so that you do not spread the germs around. Make sure you dispose of your soiled tissues in a covered bin or sealed plastic bag. 

Thursday 11 February 2016

Biggest Global Health Threats of "Drug-Resistant Tuberculosis"

Drug Resistant Tuberculosis

DRTB is defined as a form of TB infection caused by bacterial stain resistant to Anti Tuberculosis Agent which used in its treatment.

Many cases of  Tuberculosis Disease can be cured with antibiotics treatment as First-line drugs which are :-



  • Isoniazid
  • Rifampicin
  • Pyrazinamide
  • Ethambutal
  • Streptomycin
But TB bacterium resist to antibiotics are vary common which arise due to improper management or improper use of antibiotics in chemotherapy of Drug-Susceptible TB patient.This improper management means administration of improper treatment regimens &/or incomplete the course of treatment.This is called Drug-resistant Tuberculosis Disease (DRTB) which is very lethal to human being because it vary difficult to Doctor to cure this due to limited drugs are available. 

The medical aid organization Medecins Sans Frontieres/Doctors Without Borders  has published a briefing paper about the alarming spread of deadly strains of drug-resistant tuberculosis (DR-TB) is one of the biggest global health threats we face today. It calls on governments, pharmaceutical companies and researchers to mobilise urgently to save more lives and find new treatments to stem the virulent disease.



Every year, around eight million people worldwide fall ill with tuberculosis (TB) and 1.3 million people die from the infectious airborne disease.   In Ireland in 2013, 384 cases of TB were reported, representing on average one person being diagnosed with the disease every day.   TB is curable, but an inadequate global response has allowed drug-resistant TB to take a hold.

Around half a million new cases of Drug-resistant TB  occur every year and are reported in virtually all countries worldwide, with even harder to treat forms reported in nearly 100 countries. Now these deadlier DR-TB strains are spreading from person to person. Yet today, no matter where you live, there is no means to treat it effectively.

Now Tuberculosis bacterium become a more powerful bacteria due to its resistance power against antibiotics.If we are not to be alert about DRTB,the tuberculosis will gets untreatable. Therefore DRTB become a global health problem & we should proper guide to people that how protect to us against TB  & also guide to  Drug-Susceptible TB patient to complete the  exact course of treatment  to increase the chance of successful eradication of infection and to reduce the risk of antibiotic resistance developing.If normal person come in contact to DRTB patient then normal person directly receive to drug resistant bacterium. Therefore it is vary necessary to isolate the drug resistant TB patients from community because these patient do't affected to other person.


Types of Drug-Resistant Tuberculosis:

There are two main types of drug resistant TB:
  1. Multi-Drug Resistant Tuberculosis (MDR TB)
  2. Extensively-Drug Resistant Tuberculosis (XDR TB)
Another type of drug resistant TB is:-
  • Total-Drug Resistant Tuberculosis (TDR TB)
Multi-Drug Resistant Tuberculosis (MDR TB):

MDR TB is the name given to TB when the bacteria (that are causing it) are resistant to at least two of the most powerful First-Line anti TB drugs,Isoniazid & Rifampicin.


Extensively-Drug Resistant Tuberculosis (XDR TB):

XDR TB is defined as strain resistant to at least Rifampicin & Isoniazid in addition to being resistant to one of the Fluoroquinolones  as well as resistant to at least one of the second line injection TB drugs Amikacin,Kanamycin or capreomycin.

TB drugs for the treatment of drug resistant TB:

For the treatment of drug resistant TB, the current TB drugs are grouped according their effectiveness, experience of use, and drug class, as shown below.
All the drugs in Groups 2 to 5, apart from streptomycin, are referred to as “second line” or reserve TB drugs.
The first four groups of TB drugs listed below, are those that are mainly used for the treatment of drug resistant TB. The fifth group of TB drugs are some drugs that are unknown in how effective they are in the treatment of TB, but they can be tried when there is no other option. An example is using them in the treatment of totally drug resistant TB. 
TB drugs used to treat drug resistant TB according to group (class)

Group 1 TB drugs : First Line Oral Agents-
                                        
                                       pyrazinamide
                                        ethambutol
                                        rifabutin

Group 2 TB drugs : Injectable Agents-
                                       
                                        kanamycin
                                        amikacin
                                        capreomycin
                                        streptomycin

Group 3 TB drugs : Fluoroquinolones-
                                        
                                        levofloxacin
                                        moxifloxacin
                                        ofloxacin

Group 4 TB drugs : Oral Bacteriostatic Second Line Agents-
                                        
                                        para–aminosalicylic acid
                                        cycloserine
                                        terizidone
                                        thionamide
                                        protionamide
Group 5 TB drugs: Agents with an unclear role in the treatment of drug                                                        
resistant TB -
                                       
                                       clofazimine
                                       linezolid
                                       amoxicillin/clavulanate
                                       thioacetazone
                                       imipenem/cilastatin
                                       high dose isoniazid
                                       clarithromycin